Purdue Pharma Intends to Appeal Ruling on Reorganization Plan

December 17, 2021, 2:56 AM UTC

Purdue Pharma intends to appeal a ruling by a U.S. district court that reversed earlier approval of its reorganization plan by a bankruptcy court in Sept., the company says in a statement.

  • Purdue says it will simultaneously continue its efforts to forge yet further consensus around a plan
  • NOTE: Purdue Pharma Appeals Judge Strikes Down Opioid Settlement (2)

To contact the reporter on this story:
Max Zimmerman in Tokyo at mzimmerman90@bloomberg.net

To contact the editor responsible for this story:
Michael Sin at msin12@bloomberg.net

© 2021 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.